Advertisement

Clinical and Translational Oncology

, Volume 10, Issue 7, pp 407–414 | Cite as

Clinical application of intensity-modulated radiotherapy for head and neck cancer

  • Olivier Ballivy
  • Ramón Galiana Santamaría
  • Alicia Lozano Borbalas
  • Ferrán Guedea Edo
Reviews

Abstract

Intensity-modulated radiotherapy (IMRT) is a modern treatment technique that allows one to shape the dose to the target volume and to reduce the dose delivered to healthy tissue. Over the last decade, IMRT has been implemented for head and neck cancer treatment, with the aim of reducing the dose delivered to the parotid glands and improving the dose coverage of complex target volumes located close to critical structures. The potential benefits of IMRT in terms of salivary function preservation and better local control have contributed to the rapid diffusion of this new technology. However, it should not be overlooked that IMRT is a novel treatment technique and that its clinical application represents a paradigm shift in the practice of radiation oncology. The purpose of this article is to review the clinical experience with IMRT for head and neck cancer treatment and to discuss some important issues related to its implementation.

Keywords

Intensity-modulated radiotherapy IMRT Head and neck cancer Parotid sparing Xerostomia Reirradiation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Harrison LB, Zelefski MJ, Pfitzer DG et al (1997) Detailed quality of life assessment in patients treated with irradiation for cancer of the base of tongue. Head Neck 19:169–175PubMedCrossRefGoogle Scholar
  2. 2.
    Epstein JB, Emerton S, Kolbinson DS et al (1999) Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21:1–11PubMedCrossRefGoogle Scholar
  3. 3.
    Huguenin P, Taussky D, Moe K et al (1999) Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume. Int J Radiat Oncol Biol Phys 45:47–52PubMedGoogle Scholar
  4. 4.
    Wijers OB, Levendag PC, Braaksma MM et al (2002) Patients with head and neck cancer cured by radiation therapy: A survey of the dry mouth syndrome in long-term survivors. Head Neck 24: 737–747PubMedCrossRefGoogle Scholar
  5. 5.
    Xia P, Fu KK, Wong GW et al (2000) Comparison of treatment plans involving intensity modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48; 329-337Google Scholar
  6. 6.
    Adams EJ, Nutting CM, Convery DJ et al (2001) Potential role of intensity-modulated radiotherapy in the treatment of tumors of the maxillary sinus. Int J Radiat Oncol Biol Phys 51:579–588PubMedGoogle Scholar
  7. 7.
    De Neve W, De Gersem W, Derycke S et al (1999) Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control. Radiother Oncol 50:301–314PubMedCrossRefGoogle Scholar
  8. 8.
    Eisbruch A, Marsh LH, Martel MK et al (1998) Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: Assessment of target coverage and non-involved tissue sparing. Int J Radiat Oncol Biol Phys 41:559–568PubMedCrossRefGoogle Scholar
  9. 9.
    Butler EB, Teh BS, Grant WH III et al (1999) Smart (simultaneous modulated accelerated radiation therapy) boost: A new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 45:21–32PubMedGoogle Scholar
  10. 10.
    Chao KS, Low DA, Pérez CA et al (2000) Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience. Int J Cancer 90:92–103PubMedCrossRefGoogle Scholar
  11. 11.
    Chao KSC, Wippold FJ, Ozyigit G et al (2002) Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53:1174–1184PubMedCrossRefGoogle Scholar
  12. 12.
    Lee N, Xia P, Fischbein NJ et al (2003) Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 57:49–60PubMedCrossRefGoogle Scholar
  13. 13.
    Yao M, Dornfeld KJ, Buatti JM et al (2005) Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma—the University of Iowa experience. Int J Radiat Oncol Biol Phys 63:410–421PubMedGoogle Scholar
  14. 14.
    Feng M, Jabbari S, Lin A et al (2005) Predictive factors for loco-regional (LR) failures after intensity modulated radiotherapy (IMRT) for head and neck (HN) cancers. Radiother Oncol 77:32–38PubMedCrossRefGoogle Scholar
  15. 15.
    Studer G, Huguenin PU, Davis JB et al (2006) IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients. Radiat Oncol 31:1–7Google Scholar
  16. 16.
    Kwong DLW, Pow EHN, Sham JST et al (2004) Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: A prospective study on disease control and preservation of salivary function. Cancer 101:1584–1593PubMedCrossRefGoogle Scholar
  17. 17.
    Kam MK, Teo PM, Chau RM et al (2004) Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60:1440–1450PubMedGoogle Scholar
  18. 18.
    Wolden SL, Chen WC, Pfister DG et al (2006) Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64:57–62PubMedGoogle Scholar
  19. 19.
    de Arruda FF, Puri DR, Zhung J et al (2006) Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64:363–373PubMedGoogle Scholar
  20. 20.
    Garden AS, Morrison WH, Wong P et al (2007) Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 67:438–444PubMedGoogle Scholar
  21. 21.
    Hodge CW, Bentzen SM, Wong G et al (2007) Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An interera comparison. Int J Radiat Oncol Biol Phys, 69:1032–1041PubMedGoogle Scholar
  22. 22.
    Lee N, O’Meara W, Chan K et al (2007) Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 69:459–468PubMedGoogle Scholar
  23. 23.
    Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098PubMedCrossRefGoogle Scholar
  24. 24.
    Jabbari S, Kim HM, Feng M et al (2005) Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 63:725–731PubMedGoogle Scholar
  25. 25.
    Braam PM, Terhaard CHJ, Roesink JM et al (2006) Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys 66:975–980PubMedGoogle Scholar
  26. 26.
    Fang FM, Tsai WL, Chen HC et al (2007) Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma. Cancer 109:313–321PubMedCrossRefGoogle Scholar
  27. 27.
    Graff P, Lapeyre M, Desandes E et al (2007) Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67:1309–1317PubMedGoogle Scholar
  28. 28.
    Lee NY, de Arruda FF, Puri DR et al (2006) A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66:966–974PubMedGoogle Scholar
  29. 29.
    Pow EHN, Kwong DLW, McMillan AS et al (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66:981–991PubMedGoogle Scholar
  30. 30.
    Yao M, Karnell L, Funk G et al (2007) Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 69: 1354–1360PubMedGoogle Scholar
  31. 31.
    Duthoy W, Boterberg T, Claus F et al (2005) Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: Clinical results in 39 patients. Cancer 104:71–82PubMedCrossRefGoogle Scholar
  32. 32.
    Daly M, Chen A, Bucci MK et al (2007) Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 67:151–157PubMedGoogle Scholar
  33. 33.
    Hoppe BS, Stegman LD, Zelefsky MJ et al (2007) Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting-The MSKCC experience. Int J Radiat Oncol Biol Phys 67:691–702PubMedGoogle Scholar
  34. 34.
    Chua DTT, Sham JST, Leung LHT et al (2005) Reirradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol 77:290–294PubMedCrossRefGoogle Scholar
  35. 35.
    Lee N, Chan K, Bekelman JE et al (2007) Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 68:731–740PubMedGoogle Scholar
  36. 36.
    Sulman EP, Schwartz DL, Morrison WH et al (2006) 2364: IMRT re-irradiation for locoregionally recurrent or in-field second primary head and neck cancer. Int J Radiat Oncol Biol Phys 66:S412–S413Google Scholar
  37. 37.
    Sher DJ, Posner MR, Norris CM et al (2006) 2440: Re-irradiation with IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys 66:S454–S455Google Scholar
  38. 38.
    Intensity Modulated Radiation Therapy Collaborative Working Group (2001) Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 51:880–914Google Scholar
  39. 39.
    Galvin J, Ezzell G, Eisbrauch A et al (2004) Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 58:1616–1634PubMedCrossRefGoogle Scholar
  40. 40.
    Nowak PJCM, Wijers OB, Lagerwaard FJ et al (1999) A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys 45:33–39PubMedGoogle Scholar
  41. 41.
    Gregoire V, Coche E, Cosnard G et al (2000) Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 56:135–50PubMedCrossRefGoogle Scholar
  42. 42.
    Apisarnthanarax S, Elliott D, El-Naggar A et al (2006) Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys 64:678–683PubMedGoogle Scholar
  43. 43.
    Grégoire V, Levendag P, Ang K et al (2003) CTbased delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69:227–236PubMedCrossRefGoogle Scholar
  44. 44.
    Grégoire V, Eisbruch A, Hamoir M, Levendag P (2006) Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 79:15–20PubMedCrossRefGoogle Scholar
  45. 45.
    Eisbruch A, Marsh LH, Dawson LA et al (2004) Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 59:28–42PubMedGoogle Scholar
  46. 46.
    Chao KSC, Bosch WR, Mutic S et al (2001) A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49:1171–82PubMedCrossRefGoogle Scholar
  47. 47.
    Madani I, Duthoy W, Derie C et al (2007) Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 68:126–135PubMedGoogle Scholar
  48. 48.
    Lee NY, Mechalakos JG, Nehmeh S et al (2008) Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 70:2–13PubMedGoogle Scholar
  49. 49.
    Mohan R, Wu Q, Manning M et al (2000) Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 46:619–630PubMedGoogle Scholar
  50. 50.
    Ang KK, Thames HD, Peters LJ (1997) Altered fractionation schedules. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. Lippincott-Raven, Philadelphia, p 119–142Google Scholar
  51. 51.
    Radiation Therapy Oncology Group (2007) Head and neck cancer protocols 0022 and 0225. www.rtog.org/members/active.html#headneck. Accessed February 27, 2008
  52. 52.
    Lauve A, Morris M, Schmidt-Ullrich R et al (2004) Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. II: Clinical results. Int J Radiat Oncol Biol Phys 60:374–387PubMedCrossRefGoogle Scholar
  53. 53.
    Wambersie A, Landgerg T (1999) ICRU Report 62: Prescribing, Recording and Reporting Photon Beam Therapy. ICRU Publication, Bethesda (MD)Google Scholar
  54. 54.
    Eisbruch A, Ten-Haken RK, Kim HM et al (1999) Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45:577–587PubMedGoogle Scholar
  55. 55.
    Roesink J, Moerland M, Battermann J et al (2001) Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 51:938–946PubMedGoogle Scholar
  56. 56.
    Roesink JM, Moerland MA, Hoekstra A et al (2004) Scintigraphic assessment of early and late parotid gland function after radiotherapy for head and neck cancer: A prospective study of dose-volume-response relationships. Int J Radiat Oncol Biol Phys 58:1451–1460PubMedCrossRefGoogle Scholar
  57. 57.
    Münter MW, Karger CP, Hoffner SG et al (2004) Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys 58:175–184PubMedCrossRefGoogle Scholar
  58. 58.
    Blanco A, Chao KSC, El Naqa I et al (2005) Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 62:1055–1069PubMedGoogle Scholar
  59. 59.
    Saarilahti K, Kouri M, Collan J et al (2005) Intensity modulated radiotherapy for head and neck cancer: Evidence for preserved salivary gland function. Radiother Oncol 74:251–258PubMedCrossRefGoogle Scholar
  60. 60.
    Saarilahti K, Kouri M, Collan J et al (2006) Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol 78:270–275PubMedCrossRefGoogle Scholar
  61. 61.
    Eisbruch A, Kim HM, Terrell JE et al (2001) Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50:695–704PubMedGoogle Scholar
  62. 62.
    Eisbruch A, Schwartz M, Rasch C et al (2004) Dysphagia and aspiration after chemoradiotherapy for head-and neck cancer: Which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 60:1425–1439PubMedGoogle Scholar
  63. 63.
    neck cancer: Which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 60:1425–1439Google Scholar
  64. 64.
    Sanguinetti G, Endres EJ, Gunn BG et al (2006) Is there a “mucosa-sparing” benefit of IMRT for head-and-neck cancer? Int J Radiat Oncol Biol Phys 66:931–938.Google Scholar
  65. 65.
    Ploquin N, Lau H, Dunscombe P (2006) Intensity modulated and three-dimensional conformal radiation therapy plans for oropharyngeal cancer: a comparison of their sensitivity to set-up errors and uncertainties. Curr Oncol 13:61–66PubMedGoogle Scholar
  66. 66.
    Hong TS, Tomé WA, Chappell RJ et al (2005) The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 61:779–788PubMedGoogle Scholar
  67. 67.
    Hansen EK, Bucci MK, Quivey JM et al (2006) Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 64:355–362PubMedGoogle Scholar
  68. 68.
    Ballivy O, Parker W, Vuong T et al (2006) Impact of geometric uncertainties on dose distribution during intensity modulated radiotherapy of head-and-neck cancer: the need for a planning target volume and a planning organ-at-risk volume. Curr Oncol 13:108–115PubMedGoogle Scholar
  69. 69.
    Breen S, Craig T, Bayley A et al (2006) Spinal cord planning risk volumes for intensity-modulated radiation therapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 64:321–325PubMedGoogle Scholar
  70. 70.
    Boda-Hegemmann J, Walter C, Rahn A et al (2006) Repositioning accuracy of two different mask system-3D revisited: Comparison using true 3D/3D matching with cone-beam CT. Int J Radiat Oncol Biol Phys 66:1568–1575Google Scholar
  71. 71.
    Ding G, Duggan D, Coffey C et al (2007) A study on adaptive IMRT treatment planning using kV cone-beam CT. Radiother Oncol 85:116–125PubMedCrossRefGoogle Scholar
  72. 72.
    Eisbruch A, Harris J, Garden A et al (2006) 79: Phase II multi-institutional study of IMRT for oropharyngeal cancer (RTOG 00-22): Early results. Int J Radiat Oncol Biol Phys 66:S46–S47Google Scholar

Copyright information

© Feseo 2008

Authors and Affiliations

  • Olivier Ballivy
    • 1
  • Ramón Galiana Santamaría
    • 1
  • Alicia Lozano Borbalas
    • 1
  • Ferrán Guedea Edo
    • 1
  1. 1.Servicio de Oncología Radioterápica Institut Català d’OncologiaL’Hospitalet de LlobregatBarcelonaSpain

Personalised recommendations